2breathe Technologies Ltd

Digital therapeutic devices to lower high blood pressure, reduce stress and induce sleep

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
2breathe Technologies Ltd
09/01/2014
1-10

Our founders, Dr. Benjamin Gavish and his son, Erez Gavish, pioneered the digital therapeutic device field, first in hypertension and now in sleep. The original product, RESPeRATE, is the world’s only FDA-cleared, non-invasive hypertension treatment device. Used by hundreds of thousands of patients and is featured in the American Heart Association statement on non-pharmacological treatments. RESPeRATE only “side effect” was that users were falling asleep as they used it. When 90% of users reported that beyond lowering their blood pressure, it also improved their sleep, we decided to turn the “side effect into a feature” and adapt the technology to help the millions who suffer from sleeplessness. We went back to the drawing board and redesigned the effective device-guided breathing technology into a sleek smartphone powered product.